Sarepta presents preclinical SRP-1003 data in DM1
The company presented data at the 2026 Oligonucleotide Therapeutics Society Annual Meeting showing robust knockdown of pathogenic DMPK RNA in the nucleus with SRP-1003.
The company presented data at the 2026 Oligonucleotide Therapeutics Society Annual Meeting showing robust knockdown of pathogenic DMPK RNA in the nucleus with SRP-1003.